Gerald Lieberman, Director at Teva Pharmaceutical, holds 130.15K shares in Teva Pharmaceutical (Ticker: TEVA), holds 363.25K shares in Entera Bio (Ticker: ENTX), holds 274.49K shares in AllianceBernstein (Ticker: AB).
Gerald Lieberman latest transaction was an Uninformative Buy of $495.48K.
What was Gerald Lieberman's most profitable transaction?
Gerald Lieberman’s most profitable transaction was an Informative Buy of ENTX stock on December 27, 2023. The return on the trade was 241.20%.
What is Gerald Lieberman's role in Teva Pharmaceutical?
Gerald Lieberman's role in Teva Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.